Colorectal clinical trials: what is on the horizon?

被引:1
|
作者
Ahn, Daniel H. [1 ]
Goldberg, Richard M. [1 ]
机构
[1] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Div Med Oncol, 460 W 10th Ave, Columbus, OH 43210 USA
关键词
colorectal cancer; immunotherapy; next-generation sequencing; targeted therapy; WILD-TYPE KRAS; MICROSATELLITE INSTABILITY; BRAF MUTATION; OPEN-LABEL; ACQUIRED-RESISTANCE; GENE AMPLIFICATION; CANCER STATISTICS; PLUS IRINOTECAN; RAS MUTATIONS; SOLID TUMORS;
D O I
10.2217/fon.15.327
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Substantial progress has been made in the treatment of colorectal cancer, where more effective therapies have led to improved outcomes in patients with advanced disease. However, the 5-year overall survival rate remains poor. Genomic sequencing has allowed us to understand that colorectal cancer is a heterogeneous disease, where tumor-specific variants affect the prognosis and outcomes in patients. This has shaped the future directions of treatment and the development of clinical trials, including the incorporation of novel targeted therapies and investigations into the role of immunotherapy in colorectal cancer.
引用
收藏
页码:525 / 531
页数:7
相关论文
共 50 条
  • [1] Malaria vaccine clinical trials: what's on the horizon
    Moreno, Alberto
    Joyner, Chester
    CURRENT OPINION IN IMMUNOLOGY, 2015, 35 : 98 - 106
  • [2] Current clinical trials for craniopharyngiomas: what's on the horizon?
    Joshi, Nikhil
    Mueller, Sabine
    Kline, Cassie
    JOURNAL OF NEURO-ONCOLOGY, 2025, 172 (02) : 281 - 288
  • [4] Clinical trials: what a waste
    Ioannidis, John P. A.
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [5] Colorectal cancer vaccines in clinical trials
    Speetjens, Frank M.
    Zeestraten, Eliane C. M.
    Kuppen, Peter J. K.
    Melief, Cornelis J. M.
    van der Burg, Sjoerd H.
    EXPERT REVIEW OF VACCINES, 2011, 10 (06) : 899 - 921
  • [6] On the horizon: Clinical trials of new immunosuppressive strategies for autoimmune diseases
    Daikh, DI
    Wofsy, D
    TRANSPLANTATION PROCEEDINGS, 1998, 30 (08) : 4027 - 4028
  • [7] Systemic sclerosis phase III clinical trials: Hope on the horizon?
    Aringer, Martin
    Denton, Christopher P.
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2018, 3 (03) : 193 - 200
  • [8] What should be considered in clinical trials?
    Ehlers, Alexander P. F.
    Bartholomae, Julian
    Becker, Carolin
    ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE, 2023, 161 (04): : 359 - 365
  • [9] The clinical trials directive: What next?
    Saul, H
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (07) : 915 - 916
  • [10] Clinical trials: what price progress?
    Larkin, M
    LANCET, 1999, 354 (9189): : 1534 - 1534